Use App
Trending
News
Earnings
Newsletters
Advertise
All
DIA
2.49%
SPY
2.97%
QQQ
3.33%
Trending
XRP
12.21%
ZEC
19.36%
1DOG
81.82%
BTC
7.88%
MTEX
16.13%
PI
10.89%
XXRP
45.37%
HBAR
15.99%
XAR
5.92%
RNMBY
0.79%
XRP
12.21%
ZEC
19.36%
1DOG
81.82%
BTC
7.88%
MTEX
16.13%
PI
10.89%
XXRP
45.37%
HBAR
15.99%
XAR
5.92%
RNMBY
0.79%
home
Symbol
RAPP
RAPP
Rapport Therapeutics Inc
408
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
News
all
press releases
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal
Rapport Therapeutics stock jumps 62% in a week as mid-stage study of RAP-219 meets goals in drug-resistant epilepsy patients.
Zacks
·
29d ago
Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened
The company said that it now plans to advance the investigational therapy into two late-stage trials in the third quarter of 2026.
Stocktwits
·
1mo ago
Full Article
Latest RAPP News
View
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile